BERZERO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 376
NA - Nord America 366
AS - Asia 305
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 1.054
Nazione #
US - Stati Uniti d'America 366
CN - Cina 217
SE - Svezia 209
SG - Singapore 76
RU - Federazione Russa 59
IT - Italia 55
IE - Irlanda 17
FI - Finlandia 12
DE - Germania 10
ES - Italia 6
FR - Francia 6
A1 - Anonimo 5
IN - India 4
PH - Filippine 3
HK - Hong Kong 2
TW - Taiwan 2
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 1.054
Città #
New York 138
Shanghai 78
Lawrence 62
Princeton 62
Singapore 47
Dublin 17
Guangzhou 14
Milan 13
Moscow 13
Helsinki 9
Shenzhen 9
Naples 8
Ashburn 7
Beijing 7
Hangzhou 5
Jiaxing 5
Boardman 4
Bolzano 4
Rome 4
Wuxi 4
Bari 3
Cabanatuan City 3
Dallas 3
Lappeenranta 3
Quanzhou 3
Seattle 3
Barcelona 2
Bengaluru 2
Berlin 2
Borås 2
Dearborn 2
Foshan 2
Halle 2
Hong Kong 2
Jinhua 2
Lu'an 2
Paris 2
Reno 2
Sala Baganza 2
Taipei 2
Xi'an 2
Anshan 1
Auckland 1
Aversa 1
Chennai 1
Dongyang 1
Fermo 1
Haining 1
Hanover 1
Hefei 1
La Conner 1
Los Angeles 1
Mandeville 1
Martina Franca 1
Nanjing 1
Poggiomarino 1
Prineville 1
Pune 1
Rockville 1
San Diego 1
Tel Aviv 1
Weitang 1
Wuhan 1
Wuyuan 1
Totale 581
Nome #
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 38
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 30
CSF-based liquid biopsy pointing to a diagnosis of diffuse glioma in a patient with supposed neurodegenerative disorder 26
Stroke-like events after brain radiotherapy: a large series with long-term follow-up 21
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 20
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies 20
Herpes simplex encephalitis in glioma patients: A challenging diagnosis 19
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 19
CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies 19
Glioblastomas 19
The coming of age of liquid biopsy in neuro-oncology 18
In vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective Study 18
Isolated seizures are a common early feature of paraneoplastic anti-GABA B receptor encephalitis 18
Meningeal melanomatosis: a challenge for timely diagnosis 18
Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies 18
Current therapeutic approaches to diffuse grade II and III gliomas 18
Author response 18
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability 18
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 17
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies 17
Facing contrast-enhancing gliomas: Perfusion MRI in grade III and grade IV gliomas according to tumor area 17
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 17
Episodic Memory Impairments in Primary Brain Tumor Patients 17
Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity 17
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors 16
Targeting glioblastoma stem-cells: A recurrent challenge in neuro-oncology 16
Acute late-onset encephalopathy after radiotherapy: An unusual life-threatening complication 16
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies 16
Neurological syndromes associated with anti-gad antibodies 16
Brain metastases from lung cancer: Is MET an actionable target? 16
The clinical use of IDH1 and IDH2 mutations in gliomas 16
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas 16
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient 16
Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature 16
Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice 16
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study 16
Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma 15
Cranial nerve palsies in patients with hematological malignancies: a case series 15
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 15
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors 15
Anti-Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors 15
Viral infections of the nervous system 15
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci 15
Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients 15
Initial clinical presentation of young children with N-methyl-D-aspartate receptor encephalitis 15
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 15
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes 14
Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor? 14
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy 14
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 14
Paraneoplastic cerebellar degeneration associated with Anti-ITPR1 antibodies 14
Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine 14
Neurological paraneoplastic syndromes: An update 14
MINCR: A long non-coding RNA shared between cancer and neurodegeneration 14
IDH-wildtype lower-grade diffuse gliomas: The importance of histological grade and molecular assessment for prognostic stratification 14
Advanced neuroimaging studies: a patient-centered revolution 13
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 13
The molecular landscape of glioma in patients with Neurofibromatosis 1 13
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies 13
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 13
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 13
Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review 13
Late-onset vascular complications of radiotherapy for primary brain tumors: a case–control and cross-sectional analysis 12
Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity 12
Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretation 12
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors 12
Motor neuron disease of paraneoplastic origin: a rare but treatable condition 11
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma 11
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults 10
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 10
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 10
Hypersomnia in anti-glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study 9
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 9
Liquid biopsy in brain tumors: moving on, slowly 7
Totale 1.161
Categoria #
all - tutte 16.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 1 0 0 0 0 1 0 0 0 0
2021/202282 0 0 0 0 10 1 63 2 1 2 0 3
2022/2023401 139 87 19 4 4 56 19 20 29 1 5 18
2023/2024359 6 26 31 19 16 153 24 26 2 4 5 47
2024/2025317 127 16 25 49 100 0 0 0 0 0 0 0
Totale 1.161